Mikael von Euler

Born: 1953
Nationality: Swedish

Education and professional experience: Mikael von Euler is a licensed physician with a PhD from Karolinska Institutet. Von Euler is a trained oncologist with more than 30 years of experience from the pharmaceutical industry. He was previously Senior Vice President and CMO of Aprea Therapeutics, CMO of KDevOncology, Akinion, Axelar and Oncos Therapeutics (now Targovax). He has held several senior positions within the global organization of large pharmaceutical companies, including Cluster Head of Roche/Genentech, Vice President of GlaxoSmithKline and Global Product Director of AstraZeneca.
Other assignments: Board member of Dicot AB.

Independent in relation to the Company and its management as well as in relation to the Company’s major shareholders.
Shareholding in the Company: 240 000 shares